GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nova Mentis Life Science Corp (XCNQ:NOVA) » Definitions » 6-1 Month Momentum %

Nova Mentis Life Science (XCNQ:NOVA) 6-1 Month Momentum % : -25.00% (As of Jun. 21, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Nova Mentis Life Science 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-06-21), Nova Mentis Life Science's 6-1 Month Momentum % is -25.00%.

The industry rank for Nova Mentis Life Science's 6-1 Month Momentum % or its related term are showing as below:

XCNQ:NOVA's 6-1 Month Momentum % is ranked worse than
73.78% of 1522 companies
in the Biotechnology industry
Industry Median: -4.155 vs XCNQ:NOVA: -25.00

Competitive Comparison of Nova Mentis Life Science's 6-1 Month Momentum %

For the Biotechnology subindustry, Nova Mentis Life Science's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nova Mentis Life Science's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nova Mentis Life Science's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Nova Mentis Life Science's 6-1 Month Momentum % falls into.



Nova Mentis Life Science  (XCNQ:NOVA) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nova Mentis Life Science  (XCNQ:NOVA) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Nova Mentis Life Science 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Nova Mentis Life Science's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nova Mentis Life Science (XCNQ:NOVA) Business Description

Traded in Other Exchanges
Address
700-838 West Hastings Street, Vancouver, BC, CAN, V6C 0A6
Nova Mentis Life Science Corp is a Canadian-based biotechnology company. It is engaged in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory disorders. Nova uses psilocybin in the treatment of Fragile X Syndrome (FXS). The company's goal is to diagnose and treat debilitating chronic conditions that have unmet medical needs such as autism spectrum disorder (ASD) and FXS. It has one industry segment, being research and development of psilocybin, and in one geographic area, which is Canada.
Executives
Derek Lloyd Harry Ivany 10% Security Holder, Director, Senior Officer